Director, Epidemiology

Are you ready to lead and innovate in a dynamic, patient-focused biopharmaceutical company?

Ipsen is a growing global specialty-driven biopharmaceutical company focused on innovation and specialty care. We aim to make a sustainable difference by significantly improving patients’ health and quality of life, providing effective therapeutic solutions for unmet medical needs through differentiated and innovative medicines in Oncology, Neurosciences, and Rare Diseases.

Why Ipsen?

• Patient‑Focused: The patient is at the heart of everything we do, and improving their outcomes is the deliverable of every strategy.
• Employee Care: We care for our employees, who are the ambassadors making a real difference.
• Bold Leadership: We attract and develop bold, agile, entrepreneurial individuals who take full ownership of their decisions.
• Growth Opportunities: We offer a wealth of fulfilling challenges and growth opportunities in a fast‑moving, game‑changing organization.

About The Role

The Director, Epidemiology and RWE Sciences will support pre‑and post‑launch evidence generating activities across all Oncology products.

You will define and execute integrated evidence plans (IEPs), oversee RWE studies and partner closely with Global Medical Affairs, Clinical Development, Regulatory Affairs, Market Access, HEOR, Biostatistics, and Safety.

The role operates in a global, matrixed environment and ensures evidence generation adheres to scientific, regulatory, and compliance standards.

Main Responsibilities

• Be responsible for methodological epidemiological & RWE leadership and will contribute the development of new SOPs and guidance documents that will promote and ensure timely and high-quality, “fit-for-purpose” evidence generation.
• Take a lead in serving as a subject matter expert and in building capacity for RWE research across the business.
• Responsible for leading the global evidence strategy and real‑world evidence generation for Ipsen’s oncology assets across the product lifecycle.
• Provide scientific and strategic leadership to ensure that robust, fit‑for‑purpose RWE is generated to support regulatory, payer, clinical, and medical decision‑making, with a strong focus on high‑unmet‑need oncology indications.

Evidence Strategy And Leadership

• Partner effectively across the enterprise to support the identified evidence needs across Oncology and play a central role in designing Integrated Evidence Generation Plans (IEGPs) that address evidence gaps and contribute to the global Integrated Data and Evidence vision at Ipsen
• Provide strategic input to shape evidence that addresses regulatory, HTA, payer, clinician, and patient needs.
• In partnership with the Asset Teams, drive the RWE strategy per asset as part of IEGPs
• Conduct critical review of RWE/Epidemiology studies designed by external service providers and/or cross‑functional partners to ensure scientific robustness and alignment with strategic goals.
• Ensure the fulfilment of timely, high-quality epidemiology/RWE sections of Regulatory documents for agencies worldwide, including submissions, RMPs, breakthrough or orphan designations, advisory committee briefing books, etc.
• Support External Innovation and Business Development teams in assessment of external licensing opportunities by providing timely disease population assessments.
• Partner with Clinical Development teams to provide Epi support for study design and planning activities.
• Engage externally with academic collaborators, patient registries, data partners, and methodological experts to advance Ipsen’s evidence capabilities and scientific reputation.

Real‑World Evidence Generation

• Design prospective and retrospective pharmaco‑epidemiology studies (including RWE studies) in the pre-/post‑launch setting, including related to Regulatory post‑approval commitments.
• Develop and adopt robust, fit‑for‑purpose data generation and analytic methodologies that advance research goals across different life cycle management stages.
• Drive the adoption of modern RWE methodologies and analytic techniques to generate impactful evidence in settings where conventional approaches may be limited.
• Apply and champion innovative study designs and modern analytics, such as pragmatic approaches, hybrid designs, external control arms, advanced causal inference methods, and longitudinal disease modeling, as appropriate.
• Oversee vendor‑led and internally led RWE studies, including protocol development, study governance, timelines, quality, and budgets.
• Ensure methodological rigor while balancing scientific innovati